What Medical Review Means on This Site
glp1medications.org publishes YMYL (Your Money or Your Life) content — specifically, educational content about prescription GLP-1 medications. This type of content carries real-world consequences if it is inaccurate, outdated, or misleading. We take that seriously.
"Medical review" on this site refers to the process of checking factual claims about medications — including approved indications, safety profiles, regulatory status, and clinical distinctions — against official primary sources before publication. It does not mean individualized clinical evaluation of reader cases, and it does not make the content on this site equivalent to medical advice from a licensed clinician.
What this site does and does not provide
- This site provides: General educational information about GLP-1 medications, sourced to official FDA labeling, FDA guidance documents, and manufacturer prescribing information.
- This site does not provide: Individualized medical advice, diagnosis, dosing guidance, titration schedules, injection instructions, eligibility determinations, or prescription recommendations.
- Content on this site is not a substitute for evaluation by a licensed clinician who knows your medical history, current medications, and individual health context.
Reviewer Qualifications
Transparency: no named physician reviewer on staff
glp1medications.org does not currently have a named physician reviewer or medical director on staff. We are not willing to list a physician reviewer's name and credentials unless a genuine, ongoing clinical review relationship exists. Doing so would be misleading — to readers and to search engines evaluating content quality on medical topics.
We are aware that many health websites list named reviewers whose involvement may be nominal or outdated. We have chosen not to follow that practice.
In place of a named reviewer, every medical and regulatory claim on this site is:
- Sourced to an official, publicly verifiable primary document — FDA-approved prescribing information, FDA drug safety communications, FDA press announcements, or manufacturer label data.
- Linked directly to that source in the Sources section of the relevant page, so readers can verify the claim without relying on this site's editorial judgment.
- Written against a compliance framework that enforces indication accuracy, brand/indication distinctions, and explicit prohibition of clinical advice, dosing guidance, and no-prescription language.
If a qualified medical reviewer joins our editorial team in the future, this page will be updated to accurately describe their credentials, the scope of their review involvement, and when their review process began — not retroactively applied to content they did not review.
What Gets Reviewed
Every page published on glp1medications.org that contains medical or regulatory claims about a GLP-1 medication is checked against the following before publication:
FDA-approved indication accuracy
Each medication's approved indication is verified against current prescribing information. We distinguish medications approved for chronic weight management from those approved for type 2 diabetes. We do not describe Ozempic or Mounjaro as weight-loss-approved brands.
Safety and contraindication language
Safety information — including known side effects, warnings, and contraindications — is drawn from FDA-approved labeling and FDA safety communications. We do not minimize or omit clinically significant risks.
Compounded vs. FDA-approved distinction
Compounded versions of semaglutide or tirzepatide are never described as equivalent to or interchangeable with FDA-approved brand medications. We note the regulatory and quality distinctions on every relevant page.
OTC and supplement separation
Supplements, patches, gummies, drops, and research peptides marketed as GLP-1 alternatives are clearly described as not equivalent to prescription FDA-approved medications, and are not monetized on this site.
Coverage and cost qualification
Coverage and cost content is reviewed to ensure no guaranteed coverage, guaranteed approval, or specific cost promise appears. All such content uses language reflecting real plan-specific variability.
No clinical advice in published content
Published pages are reviewed to confirm they do not contain dosing schedules, titration instructions, injection guidance, reconstitution instructions, or individualized eligibility determinations.
Update Policy
GLP-1 medications are a rapidly evolving regulatory category. FDA guidance, prescribing information, shortage notices, compounding policy, and insurance coverage rules can change substantially in a short period. Our update standards reflect this:
- Pages are reviewed when significant regulatory changes occur. This includes new FDA approvals, label updates, safety communications, major changes to compounding policy, and changes that affect the accuracy of published indication or safety content.
- A "Last reviewed" date on a page indicates when editorial staff last verified the page's primary sources against current official guidance. It does not guarantee that every claim reflects the most current prescribing information at the moment you read it.
- We acknowledge that content can become outdated between review cycles. Readers should verify current medication information with a licensed clinician and confirm coverage details with their insurer before making treatment decisions.
- Correction requests are reviewed when a reader identifies a specific factual claim that conflicts with an official primary document. Corrections are applied when the claim is confirmed as inaccurate against official sources. See the Editorial Policy for how to submit a correction.
Information may change — always verify with a clinician
Even recently reviewed content on this site may not reflect the latest FDA guidance or your plan's current formulary. Treatment decisions require evaluation by a licensed clinician with access to current prescribing information and your individual medical history.
Medical Disclaimer
Not medical advice
All content on glp1medications.org is for general educational and informational purposes only. It is not intended to be — and should not be used as — medical advice, diagnosis, or treatment guidance for any individual.
GLP-1 medications are prescription drugs. Whether any GLP-1 medication is appropriate for a specific individual depends on that person's medical history, current medications, health conditions, contraindications, and a licensed clinician's individualized evaluation. No website, medical review policy, or comparison tool can make that determination.
Medication indications, risks, costs, and availability can change. Always talk with a licensed clinician before starting, stopping, or changing any prescription medication, and verify current information with your prescriber and insurer.
If you are experiencing a medical emergency, call 911 or go to the nearest emergency room. If you are experiencing thoughts of self-harm or suicide, call or text 988 (Suicide and Crisis Lifeline) immediately.
Related Policies
For more detail on how this site handles editorial standards, sources, affiliate relationships, and corrections, see the following pages.
For educational content about GLP-1 medications, visit our GLP-1 Medications hub.